AORT
ArtivionยทNYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AORT Profile
Artivion, Inc.
A leading cardiac and vascular surgery company focused on aortic disease
Healthcare Equipment and Supplies
--
07/15/1997
New York Stock Exchange
1,600
12-31
Common stock
1655 Roberts Boulevard N.W., Kennesaw, GA 30144
--
Incorporated in Florida in 1984 and changing its registered address from Florida to Delaware on January 1, 2022, Artivion, Inc., is a leader in the production, processing and distribution of medical devices and implantable human tissue, focusing on aortic repair. Their medical devices and processing tissues primarily include four product lines: BioGlue Surgical Adhesives (" BioGlue "); On-X Mechanical Heart Valves and Surgical Products; JOTEC Endovascular and Surgical Products; and including CryoValve SG Pulmonary Heart Valves (" CryoValve SGPV ") and CryoPatch SG Pulmonary Heart Patches (" CryoPatch S G ") including heart and vascular human tissue, both of which are processed using its proprietary SynerGraft technology. Other products include CardioGenesis Cardiac Laser Therapy, PerClot and PhotoFixTM.
